G2* (p.Gly2Ter) variant of ALK (ALK tyrosine kinase receptor)
G2* (p.Gly2Ter) in ALK (ALK tyrosine kinase receptor) is a protein-truncating change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.50 / 1. The record also includes population frequency data and structural context.
G2* (p.Gly2Ter) variant details
- p.Gly2Ter
- Ensembl rs1667974338
- Uncertain significance
- Stop Gained
- Variant Prioritization Score for Impact Estimate 0.498
- CADD 35.00
- EBI: Variant of uncertain significance
- UniProt: Uncertain significance
- Population evidence available
- Structural context available